Navigation Links
Lumension Provides Leading e-Commerce Company Proactive Endpoint Security at a High Return
Date:12/16/2008

The New Ogren Group study quantifies ROI of Lumension's integrated application whitelisting and vulnerability management solutions inside a real-world enterprise environment

Scottsdale, Ariz. (PRWEB) December 16, 2008 -- Demonstrating the value automated tools that align security and IT functions have on the enterprise, Lumension Security™, Inc., a leading global security management company, today made available a ROI customer case study with analysis conducted by the Ogren Group. The key findings of the report found that EC Suite, a major processor of credit card transactions for e-commerce organizations, saved considerable time and effort in their IT and security operations because of the preventive security measures and procedures available in Lumension's security solutions.

Lumension's advanced application whitelisting protects against malware and viral programs, while improving total data security and overall system performance to meet the needs of both IT security and IT operations. Additionally, Lumension's Data Protection Solution provides the control and detailed forensics required to analyze and update security polices. As a result, organizations, such as EC Suite, can more efficiently detect risks, deploy patches and defend business information across a distributed environment to positively impact a company's bottom line.

"IT security is difficult to justify from a financial return basis as security products seldom tie directly to revenue," said Eric Ogren, principal analyst Ogren Group. "Adopting preventive, proactive security solutions to manage endpoint risk will improve security coverage of all devices in the network and multiple applications, and it will save operational expenses associated with attacks or inferior products. That's a good combination that works for EC Suite."

The Ogren Group's analysis found EC Suite achieved an impressive 258 percent rate of return in the first year of operating Lumension security products, with a 964 percent average rate of return over the first three years. This calculation is based on the year-over-year cost savings of over $226,700 that EC Suite derives from integrating Lumension's vulnerability patch process with its application control whitelisting technology.

"Leveraging Lumension's security solutions has allowed us to take a proactive, integrated approach to operational security," said William Bell, director of security, ECSuite.com. "As a result, we feel better-prepared to address the security challenges, such as increased spyware, Trojan attacks and intentional or unintentional information leakages that confront our organization, to preserve the integrity of our business."

Lumension's Endpoint Protection Suite protects against targeted threats and enables only authorized applications and devices to execute or connect to a network server, terminal services server, thin client, laptop or desktop. Lumension's suite simplifies the discovery phase so that administrators can uncover all of the applications that are executing on the endpoints. Once known what applications are on the network, a policy can be established and enforced.

In addition, Lumension delivers the only vulnerability management solution that fully integrates network scanning, agent-based assessment and remediation in a single management console. For more information and to access the new case study: "Lumension Security: a Case Study in Proactively Managing Endpoint Risk."

For a free 30-day trial of Lumension's award-winning solutions, please visit lumension.com.

About Lumension Security™, Inc.

Lumension Security™, formed by the combination of PatchLink® Corporation and SecureWave® S.A., is a recognized, global security management company, providing unified protection and control of enterprise endpoints for more than 5,100 customers and 14 million nodes worldwide. Leveraging its proven Positive Security Model, Lumension Security enables organizations to effectively manage risk at the endpoint by delivering best-of-breed, policy-based solutions that simplify the entire security management lifecycle. This includes automated asset discovery, vulnerability assessment, remediation and validation; security configuration management; application control and device control; extensive policy compliance reporting; and integration with leading network access control solutions. Founded in 1991, Lumension is headquartered in Scottsdale, Arizona, with offices worldwide, including Virginia, Florida, Luxembourg, the United Kingdom, Spain, Australia, Hong Kong and Singapore. More information can be found at lumension.com.

Lumension Security, the Lumension logo, PatchLink® and Sanctuary® are trademarks or registered trademarks of Lumension Security. All other trademarks are the property of their respective owners.

###

Read the full story at http://www.prweb.com/releases/endpoint/security/prweb1755974.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Lumension Security Announces General Availability of Sanctuary Endpoint Protection and Data Protection Suite to Safeguard Data and Privacy
2. Lumension Security To Showcase Vulnerability Management Expertise With Whitehatworld.com Webcast
3. Lumension Security Launches Interactive Office Game To Educate IT Professionals On 10 Most Common Security Risks Within The Workplace
4. Lumension Security Debuts New Customer Testimonial Video
5. Lumension Security Launches Podcast On Application Whitelisting: Keep The Bad Guys Out - Let The Good Guys In
6. Lumension Security Receives Frost & Sullivan 2008 Global Market Penetration Leadership Award
7. Lumension Security To Host Industry Webinar On Staying Ahead Of Threats
8. Lumension Security to Host Industry Webinar on Protecting Vital Business Data
9. Lumension Uncovers Results of Security Data Protection Survey
10. Study provides hope that some transplant patients could live free of antirejection drugs
11. Study provides hope that some transplant patients could live free of anti-rejection drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lumension Provides Leading e-Commerce Company Proactive Endpoint Security at a High Return
(Date:1/17/2017)... ... January 17, 2017 , ... A prescription medication bottle, pocket knife, ... Cradle to Cradle Product Design Challenge , the Cradle to Cradle Products ... six circular design challenges scheduled to run through early 2018. The challenges are presented ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... Neil H. ... financial planning assistance to communities throughout the region, is launching a charity drive to ... disease is by far the deadliest killer in America, and is responsible for 1 ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... SC&H Group, ... firm as a Principal in its IT Advisory Services practice . Rossi is ... months as market demand for strategic IT guidance grows, and the practice continues to ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... to visualize, detect, and eliminate cyber threats in real-time, today announced a strategic ... provider, headquartered in Selangor, Malaysia. Joining other Seceon partners, TechLab Security has become ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... ... families from two offices in Tyler, has announced the latest beneficiary of their ... Wish Network, a nonprofit organization dedicated to fulfilling the dreams of terminally ill ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 2017 According to a new market research report "Neural Network ... Software), Vertical, and Region - Global Forecast to 2021" published by MarketsandMarkets, the ... by 2021, at a Compound Annual Growth Rate (CAGR) of 33.2%. ... ... MarketsandMarkets Logo ...
(Date:1/17/2017)... and KANSAS CITY, Mo. ... Hospitals Neonatal Consortium (CHNC) has selected Velos and ... visionary data management and multicenter initiatives. ... comprised of 32 Neonatal Intensive Care Units at ... . The consortium provides a benchmark of ...
(Date:1/17/2017)... --  Tocagen Inc ., a clinical-stage, cancer-selective gene therapy company, today ... and pharmaceutical development at Tocagen, will present at Phacilitate Cell ... in Miami . Details of ... ... viruses - what to do when and why Date and Time: ...
Breaking Medicine Technology: